Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Real-world Data from a National Early Access Program Registry

IF 8.5 1区医学 Q1 ONCOLOGY

European urology oncology Pub Date : 2026-08-01 Epub Date: 2026-06-29 DOI:10.1016/j.euo.2026.06.010

Idir Ouzaid, Pierre Bigot, Morgan Rouprêt

引用次数: 0

查看原文本刊更多论文

高风险肾细胞癌肾切除术后的派姆单抗：来自国家早期获取计划注册的真实世界数据

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology oncology Multiple-

CiteScore

15.50

自引率

2.40%

发文量

128

审稿时长

20 days

期刊介绍： Journal Name: European Urology Oncology Affiliation: Official Journal of the European Association of Urology Focus: First official publication of the EAU fully devoted to the study of genitourinary malignancies Aims to deliver high-quality research Content: Includes original articles, opinion piece editorials, and invited reviews Covers clinical, basic, and translational research Publication Frequency: Six times a year in electronic format